Martin Pharmaceuticals is Drug Discovery in United States that focus on drug shifts business. Founded in 2017. They cover business area such as developer, acute-on-chronic liver failure, ACLF, energy, fatty acid oxidation, these toxic molecule, patient, access, less damage, individual hepatocyte, less hepatocyte death.
2017
( 7 years old in 2024 )
Drug Shifts
-
233 Broadway
Suite 1750
New York, NY 10279
United States
Private
developeracute-on-chronic liver failureACLFenergyfatty acid oxidationthese toxic moleculepatientaccessless damageindividual hepatocyteless hepatocyte death
* We use standard office opening hours in near Martin Pharmaceuticals's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Martin Pharmaceuticals is Drug Discovery business from United States that founded in 2017 (7 years old in 2024), Martin Pharmaceuticals business is focusing on Drug Shifts.
Martin Pharmaceuticals headquarter office and corporate office address is located in 233 Broadway Suite 1750 New York, NY 10279 United States.
Martin Pharmaceuticals was founded in United States.
In 2024, Martin Pharmaceuticals is currently focus on drug shifts sector.
Above is snippet of Google Trends for "drug shifts" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Martin Pharmaceuticals, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
